TruScreen Group Limited (NZE:TRU)

New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0290
+0.0010 (3.57%)
May 13, 2025, 2:39 PM NZST
70.59%
Market Cap 16.09M
Revenue (ttm) 2.68M
Net Income (ttm) -1.83M
Shares Out 554.91M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 69,798
Average Volume 237,907
Open 0.0270
Previous Close 0.0280
Day's Range 0.0270 - 0.0290
52-Week Range 0.0150 - 0.0370
Beta -0.24
RSI 46.14
Earnings Date May 29, 2025

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. T... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Country New Zealand
Stock Exchange New Zealand Stock Exchange
Ticker Symbol TRU
Full Company Profile

Financial Performance

In 2023, TruScreen Group's revenue was 2.60 million, an increase of 25.18% compared to the previous year's 2.08 million. Losses were -2.05 million, -14.63% less than in 2022.

Financial Statements

News

There is no news available yet.